(Q53588712)

English

The efficacy of a combination of ondansetron, methylprednisolone and metopimazine in patients previously uncontrolled with a dual antiemetic treatment in cisplatin-based chemotherapy. The French Ondansetron Study Group.

scientific article published in September 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9358940

The efficacy of a combination of ondansetron, methylprednisolone and metopimazine in patients previously uncontrolled with a dual antiemetic treatment in cisplatin-based chemotherapy. The French Ondansetron Study Group. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9358940

methylprednisolone

1 reference

based on heuristic

inferred from title

author name string

B Lebeau

1

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9358940

A Depierre

2

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9358940

M Giovannini

3

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9358940

A Rivière

4

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9358940

L Kaluzinski

5

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9358940

B Votan

6

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9358940

M Hédouin

7

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9358940

H d'Allens

8

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9358940

publication date

1 September 1997

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9358940

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9358940

8

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9358940

9

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9358940

887-892

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9358940

Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008276412559

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008276412559

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008276412559

7 January 2021

based on heuristic

inferred from DOI database lookup

Methylprednisolone enhances the efficacy of ondansetron in acute and delayed cisplatin-induced emesis over at least three cycles. Ondansetron Study Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008276412559

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, double-blind comparison of intravenous ondansetron alone and in combination with intravenous dexamethasone in the prevention of high-dose cisplatin-induced emesis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008276412559

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008276412559

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008276412559

7 January 2021

based on heuristic

inferred from DOI database lookup

A multicentre, double-blind study comparing placebo, ondansetron and ondansetron plus dexamethasone for the control of cisplatin-induced delayed emesis. Ondansetron Delayed Emesis Study Group.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008276412559

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimum anti-emetic therapy for cisplatin induced emesis over repeat courses: ondansetron plus dexamethasone compared with metoclopramide, dexamethasone plus lorazepam.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008276412559

7 January 2021

based on heuristic

inferred from DOI database lookup

Ondansetron + dexamethasone vs metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin-induced emesis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008276412559

7 January 2021

based on heuristic

inferred from DOI database lookup

Ondansetron plus metopimazine compared with ondansetron alone in patients receiving moderately emetogenic chemotherapy.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008276412559

7 January 2021

based on heuristic

inferred from DOI database lookup

Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008276412559

7 January 2021

based on heuristic

inferred from DOI database lookup

Does dexamethasone enhance control of acute cisplatin induced emesis by ondansetron?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008276412559

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanism of the anti-emetic activity of 5-HT3 receptor antagonists

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008276412559

7 January 2021

based on heuristic

inferred from DOI database lookup

Methods and problems in measuring quality of life

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008276412559

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008276412559

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9358940

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/9358940

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53588712&oldid=2160194089"